Cargando…

Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease

Background: According to observational studies, two polymorphisms in the apolipoprotein L1 (APOL1) gene have been linked to an increased risk of chronic kidney disease (CKD) in Africans. One polymorphism involves the substitution of two amino-acid residues (S342G and I384M; known as G1), while the o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayanja, Richard, Kintu, Christopher, Diabate, Oudou, Soremekun, Opeyemi, Oluwagbemi, Olugbenga Oluseun, Wele, Mamadou, Kalyesubula, Robert, Jjingo, Daudi, Chikowore, Tinashe, Fatumo, Segun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408642/
https://www.ncbi.nlm.nih.gov/pubmed/36011371
http://dx.doi.org/10.3390/genes13081460
_version_ 1784774651685109760
author Mayanja, Richard
Kintu, Christopher
Diabate, Oudou
Soremekun, Opeyemi
Oluwagbemi, Olugbenga Oluseun
Wele, Mamadou
Kalyesubula, Robert
Jjingo, Daudi
Chikowore, Tinashe
Fatumo, Segun
author_facet Mayanja, Richard
Kintu, Christopher
Diabate, Oudou
Soremekun, Opeyemi
Oluwagbemi, Olugbenga Oluseun
Wele, Mamadou
Kalyesubula, Robert
Jjingo, Daudi
Chikowore, Tinashe
Fatumo, Segun
author_sort Mayanja, Richard
collection PubMed
description Background: According to observational studies, two polymorphisms in the apolipoprotein L1 (APOL1) gene have been linked to an increased risk of chronic kidney disease (CKD) in Africans. One polymorphism involves the substitution of two amino-acid residues (S342G and I384M; known as G1), while the other involves the deletion of two amino-acid residues in a row (N388 and Y389; termed G2). Despite the strong link between APOL1 polymorphisms and kidney disease, the molecular mechanisms via which these APOL1 mutations influence the onset and progression of CKD remain unknown. Methods: To predict the active site and allosteric site on the APOL1 protein, we used the Computed Atlas of Surface Topography of Proteins (CASTp) and the Protein Allosteric Sites Server (PASSer). Using an extended molecular dynamics simulation, we investigated the characteristic structural perturbations in the 3D structures of APOL1 variants. Results: According to CASTp’s active site characterization, the topmost predicted site had a surface area of 964.892 Å(2) and a pocket volume of 900.792 Å(3). For the top three allosteric pockets, the allostery probability was 52.44%, 46.30%, and 38.50%, respectively. The systems reached equilibrium in about 125 ns. From 0–100 ns, there was also significant structural instability. When compared to G1 and G2, the wildtype protein (G0) had overall high stability throughout the simulation. The root-mean-square fluctuation (RMSF) of wildtype and variant protein backbone Cα fluctuations revealed that the Cα of the variants had a large structural fluctuation when compared to the wildtype. Conclusion: Using a combination of different computational techniques, we identified binding sites within the APOL1 protein that could be an attractive site for potential inhibitors of APOL1. Furthermore, the G1 and G2 mutations reduced the structural stability of APOL1.
format Online
Article
Text
id pubmed-9408642
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94086422022-08-26 Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease Mayanja, Richard Kintu, Christopher Diabate, Oudou Soremekun, Opeyemi Oluwagbemi, Olugbenga Oluseun Wele, Mamadou Kalyesubula, Robert Jjingo, Daudi Chikowore, Tinashe Fatumo, Segun Genes (Basel) Article Background: According to observational studies, two polymorphisms in the apolipoprotein L1 (APOL1) gene have been linked to an increased risk of chronic kidney disease (CKD) in Africans. One polymorphism involves the substitution of two amino-acid residues (S342G and I384M; known as G1), while the other involves the deletion of two amino-acid residues in a row (N388 and Y389; termed G2). Despite the strong link between APOL1 polymorphisms and kidney disease, the molecular mechanisms via which these APOL1 mutations influence the onset and progression of CKD remain unknown. Methods: To predict the active site and allosteric site on the APOL1 protein, we used the Computed Atlas of Surface Topography of Proteins (CASTp) and the Protein Allosteric Sites Server (PASSer). Using an extended molecular dynamics simulation, we investigated the characteristic structural perturbations in the 3D structures of APOL1 variants. Results: According to CASTp’s active site characterization, the topmost predicted site had a surface area of 964.892 Å(2) and a pocket volume of 900.792 Å(3). For the top three allosteric pockets, the allostery probability was 52.44%, 46.30%, and 38.50%, respectively. The systems reached equilibrium in about 125 ns. From 0–100 ns, there was also significant structural instability. When compared to G1 and G2, the wildtype protein (G0) had overall high stability throughout the simulation. The root-mean-square fluctuation (RMSF) of wildtype and variant protein backbone Cα fluctuations revealed that the Cα of the variants had a large structural fluctuation when compared to the wildtype. Conclusion: Using a combination of different computational techniques, we identified binding sites within the APOL1 protein that could be an attractive site for potential inhibitors of APOL1. Furthermore, the G1 and G2 mutations reduced the structural stability of APOL1. MDPI 2022-08-16 /pmc/articles/PMC9408642/ /pubmed/36011371 http://dx.doi.org/10.3390/genes13081460 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mayanja, Richard
Kintu, Christopher
Diabate, Oudou
Soremekun, Opeyemi
Oluwagbemi, Olugbenga Oluseun
Wele, Mamadou
Kalyesubula, Robert
Jjingo, Daudi
Chikowore, Tinashe
Fatumo, Segun
Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
title Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
title_full Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
title_fullStr Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
title_full_unstemmed Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
title_short Molecular Dynamic Simulation Reveals Structure Differences in APOL1 Variants and Implication in Pathogenesis of Chronic Kidney Disease
title_sort molecular dynamic simulation reveals structure differences in apol1 variants and implication in pathogenesis of chronic kidney disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408642/
https://www.ncbi.nlm.nih.gov/pubmed/36011371
http://dx.doi.org/10.3390/genes13081460
work_keys_str_mv AT mayanjarichard moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT kintuchristopher moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT diabateoudou moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT soremekunopeyemi moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT oluwagbemiolugbengaoluseun moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT welemamadou moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT kalyesubularobert moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT jjingodaudi moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT chikoworetinashe moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease
AT fatumosegun moleculardynamicsimulationrevealsstructuredifferencesinapol1variantsandimplicationinpathogenesisofchronickidneydisease